Lusutrombopag

Last Updated: 06/30/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 85 publications

Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.

Thrombopoietin receptor agonists in immune thrombocytopenia: a comparative review of mechanisms, efficacy, and the future of personalized management.

Journal: Expert opinion on pharmacotherapy

Published: March 24, 2026

Efficacy and safety of lusutrombopag monotherapy for cyclosporine A-refractory, transfusion-dependent non-severe aplastic anemia

Efficacy and safety of lusutrombopag monotherapy for cyclosporine A-refractory, transfusion-dependent non-severe aplastic anemia

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 03, 2025

Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist.

Repurposing lusutrombopag: unveiling anti-Staphylococcus aureus activity in a novel oral thrombopoietin receptor agonist.

Journal: BMC microbiology

Published: September 24, 2025

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Relationship between thromboembolic events and thrombopoietin receptor agonists: a pharmacovigilance analysis of the FDA Adverse Event Reporting System and the Japanese Adverse Drug Event Report.

Journal: BMJ open

Published: August 10, 2025

Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and Its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.

Usefulness of Repeated Lusutrombopag Administration in Clinical Practice and Its Correlation with the Simulation Software-Predicted Platelet Count: A Multicenter Study.

Journal: Internal medicine (Tokyo, Japan)

Published: March 16, 2025

Development and validation of a prognostic prediction model based on coagulation-related genes and clinical factors in acute leukemia.

Development and validation of a prognostic prediction model based on coagulation-related genes and clinical factors in acute leukemia.

Journal: Translational pediatrics

Published: February 21, 2025

Lusutrombopag or hetrombopag supports in vitro megakaryopoiesis better than other thrombopoietin receptor agonists.

Lusutrombopag or hetrombopag supports in vitro megakaryopoiesis better than other thrombopoietin receptor agonists.

Journal: British journal of haematology

Published: February 05, 2025

QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation.

QSAR-Based Drug Repurposing and RNA-Seq Metabolic Networks Highlight Treatment Opportunities for Hepatocellular Carcinoma Through Pyrimidine Starvation.

Journal: Cancers

Published: January 27, 2025

Clinical research progress of lusutrombopag for the treatment of thrombocytopenia in chronic liver disease

Clinical research progress of lusutrombopag for the treatment of thrombocytopenia in chronic liver disease

Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology

Published: November 11, 2024

Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre-Treatment Platelet Counts: A Retrospective Multicenter Study.

Evaluation of the Efficacy of Lusutrombopag for Chronic Liver Disease Based on Pre-Treatment Platelet Counts: A Retrospective Multicenter Study.

Journal: JGH open : an open access journal of gastroenterology and hepatology

Published: October 29, 2024

Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease.

Pharmacist intervention through protocol-based pharmacotherapy management is effective to ensure safety in invasive procedures for chronic liver disease.

Journal: Journal of pharmaceutical health care and sciences

Published: September 02, 2024

Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics.

Update on the Use of Thrombopoietin-Receptor Agonists in Pediatrics.

Journal: Hamostaseologie

Published: June 26, 2024

Showing 1-12 of 85

Last Updated: 06/30/2026